Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (S)-colchicine | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Colchicine results in decreased expression of ORAI3 mRNA | CTD | PMID:24211769 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ORAI3 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | ORAI3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in increased expression of ORAI3 mRNA | CTD | PMID:22217510 | 17beta-estradiol | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of ORAI3 mRNA | CTD | PMID:31614463 | acrylamide | decreases expression | ISO | Orai3 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of ORAI3 mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of ORAI3 mRNA | CTD | PMID:32763439 | adenine | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Adenine results in decreased expression of ORAI3 mRNA | CTD | PMID:24211769 | aflatoxin B1 | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of ORAI3 mRNA | CTD | PMID:21632981 and PMID:21641981 | aflatoxin B1 | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of ORAI3 mRNA | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ORAI3 mRNA | CTD | PMID:33167477 | atrazine | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Atrazine results in increased expression of ORAI3 mRNA | CTD | PMID:22378314 | azoxystrobin | multiple interactions | ISO | Orai3 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ORAI3 gene | CTD | PMID:33854195 | benzo[a]pyrene | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ORAI3 mRNA | CTD | PMID:21632981 | bisphenol A | increases expression | ISO | Orai3 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ORAI3 mRNA | CTD | PMID:25181051 more ... | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of ORAI3 promoter | CTD | PMID:27312807 | butanal | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of ORAI3 mRNA | CTD | PMID:26079696 | cadmium dichloride | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of ORAI3 mRNA | CTD | PMID:25596134 | chloroacetaldehyde | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | chloroacetaldehyde results in increased expression of ORAI3 mRNA | CTD | PMID:25596134 | chlorpyrifos | multiple interactions | ISO | Orai3 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ORAI3 gene | CTD | PMID:33854195 | cisplatin | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ORAI3 mRNA | CTD | PMID:24211769 | cisplatin | multiple interactions | ISO | ORAI3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of ORAI3 mRNA | CTD | PMID:27392435 | cisplatin | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ORAI3 mRNA | CTD | PMID:27392435 | clodronic acid | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Clodronic Acid results in decreased expression of ORAI3 mRNA | CTD | PMID:25596134 | copper(II) sulfate | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ORAI3 mRNA | CTD | PMID:19549813 | cyclosporin A | affects expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Cyclosporine affects the expression of ORAI3 mRNA | CTD | PMID:25596134 | cyclosporin A | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ORAI3 mRNA | CTD | PMID:20106945 and PMID:25562108 | diazinon | increases methylation | ISO | ORAI3 (Homo sapiens) | 6480464 | Diazinon results in increased methylation of ORAI3 gene | CTD | PMID:22964155 | dibutyl phthalate | affects expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Dibutyl Phthalate affects the expression of ORAI3 mRNA | CTD | PMID:36375677 | dioxygen | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of ORAI3 mRNA | CTD | PMID:25596134 | dorsomorphin | multiple interactions | ISO | ORAI3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ORAI3 mRNA | CTD | PMID:27188386 | endosulfan | decreases expression | ISO | Orai3 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of ORAI3 mRNA | CTD | PMID:29391264 | ethyl methanesulfonate | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of ORAI3 mRNA | CTD | PMID:23649840 | ethyl methanesulfonate | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of ORAI3 mRNA | CTD | PMID:24211769 | fenofibrate | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Fenofibrate results in decreased expression of ORAI3 mRNA | CTD | PMID:25596134 | fenthion | increases expression | EXP | | 6480464 | Fenthion results in increased expression of ORAI3 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ORAI3 mRNA | CTD | PMID:22206623 | formaldehyde | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of ORAI3 mRNA | CTD | PMID:23649840 | glyphosate | multiple interactions | ISO | Orai3 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ORAI3 gene | CTD | PMID:33854195 | hydrogen peroxide | affects expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of ORAI3 mRNA | CTD | PMID:20044591 | imidacloprid | multiple interactions | ISO | Orai3 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ORAI3 gene | CTD | PMID:33854195 | lead(0) | affects expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Lead affects the expression of ORAI3 mRNA | CTD | PMID:28903495 | metformin | decreases expression | ISO | Orai3 (Rattus norvegicus) | 6480464 | Metformin results in decreased expression of ORAI3 mRNA | CTD | PMID:25596134 | methyl methanesulfonate | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of ORAI3 mRNA | CTD | PMID:23649840 | mitomycin C | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Mitomycin results in decreased expression of ORAI3 mRNA | CTD | PMID:24211769 | niclosamide | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of ORAI3 mRNA | CTD | PMID:36318118 | paracetamol | increases expression | ISO | Orai3 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of ORAI3 mRNA | CTD | PMID:33387578 | perfluorononanoic acid | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of ORAI3 mRNA | CTD | PMID:32588087 | phenobarbital | affects expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of ORAI3 mRNA | CTD | PMID:19159669 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ORAI3 mRNA | CTD | PMID:19710929 | SB 431542 | multiple interactions | ISO | ORAI3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ORAI3 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of ORAI3 mRNA | CTD | PMID:25895662 | sodium arsenite | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ORAI3 mRNA | CTD | PMID:34032870 | sunitinib | increases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of ORAI3 mRNA | CTD | PMID:31533062 | thiabendazole | multiple interactions | ISO | Orai3 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ORAI3 gene | CTD | PMID:33854195 | trichostatin A | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ORAI3 mRNA | CTD | PMID:24935251 | triptonide | increases expression | EXP | | 6480464 | triptonide results in increased expression of ORAI3 mRNA | CTD | PMID:33045310 | valproic acid | affects expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ORAI3 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | ORAI3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ORAI3 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | ORAI3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ORAI3 mRNA | CTD | PMID:27188386 | |